Pharma & Biopharma

Contract manufacturing is becoming increasingly vital in the pharmaceutical industry, particularly in cell and gene therapy due to the high demand for these innovative products. Kalorama Information’s report, Market for Cell and Gene Therapy Contract Manufacturing Organizations (CMOs), provides comprehensive insights into this dynamic market.

Report Highlights:

• Biopharmaceutical Contract Manufacturing Market: In-depth analysis of…

Outsourcing drug discovery represents the initial phase of the drug development process. By outsourcing segments of their drug discovery programs, pharmaceutical and biotechnology companies have discovered a cost-effective strategy that enhances hit-to-lead conversion and early identification of ineffective compounds. Outsourcing accelerates the drug discovery process, transforming the industry from low-end research services to high-value, sophisticated…

Non-alcoholic steatohepatitis (NASH) is a serious liver disease characterized by inflammation and liver cell damage, which can lead to cirrhosis. Despite the absence of approved medications specifically for NASH, there are nearly 80 drug candidates in development. Kalorama Information’s report, NASH Drug Pipeline and Market Overview, provides an in-depth analysis of these drug candidates, including…

CAR-T Cell Therapy Market Review provides an insightful examination of CAR-T therapy, a revolutionary form of immunotherapy harnessing the body’s T cells to target and eradicate cancer cells. This report delves into the technology behind CAR-T, its application in treating diseases like acute lymphoblastic leukemia, DLBCL B-cell lymphomas, and multiple myeloma.

Key Objectives and Questions…

Biosimilar Market Trends, 2019 offers insights into the dynamic landscape of biosimilar markets worldwide. This comprehensive report delves into the strategies employed by both innovator and generic companies, providing a snapshot of key trends and issues influencing the biosimilar industry. With coverage spanning biopharmaceuticals, the report examines regulatory environments, market opportunities, and challenges, offering invaluable…